Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations
Authors
Keywords
Gemcitabine, Mutant p53, p53 family, RUNX2
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-04
DOI
10.1186/s12885-018-4217-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer
- (2017) Weiwei Sheng et al. FASEB JOURNAL
- Plk1 inhibition enhances the efficacy of gemcitabine in human pancreatic cancer
- (2016) Jie Li et al. CELL CYCLE
- Efficacy and safety of gemcitabine plus erlotinib for locally advanced or metastatic pancreatic cancer: a systematic review and meta-analysis
- (2016) Yuan Wang et al. Drug Design Development and Therapy
- Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TAp63
- (2016) Toshinori Ozaki et al. Oncotarget
- Improvement of gemcitabine sensitivity of p53-mutated pancreatic cancer MiaPaCa-2 cells by RUNX2 depletion-mediated augmentation of TAp73-dependent cell death
- (2016) M Nakamura et al. Oncogenesis
- Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine
- (2015) Claudia Fiorini et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis
- (2015) Alison Roos et al. BRITISH JOURNAL OF CANCER
- Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease
- (2015) H. Taipaleenmaki et al. CANCER RESEARCH
- Pontin, a new mutant p53-binding protein, promotes gain-of-function of mutant p53
- (2015) Y Zhao et al. CELL DEATH AND DIFFERENTIATION
- Loss of ATF3 promotes hormone-induced prostate carcinogenesis and the emergence of CK5+CK8+ epithelial cells
- (2015) Z Wang et al. ONCOGENE
- Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma
- (2015) Saba Mohamed El-Gendi et al. PATHOLOGY & ONCOLOGY RESEARCH
- ΔNp63α enhances the oncogenic phenotype of osteosarcoma cells by inducing the expression of GLI2
- (2014) Ram Mohan Ram Kumar et al. BMC CANCER
- Integrin v 6 Promotes an Osteolytic Program in Cancer Cells by Upregulating MMP2
- (2014) A. Dutta et al. CANCER RESEARCH
- Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity
- (2014) Toshinori Ozaki et al. FEBS Journal
- MicroRNA-23b is an independent prognostic marker and suppresses ovarian cancer progression by targeting runt-related transcription factor-2
- (2014) Weiping Li et al. FEBS LETTERS
- The Activating Transcription Factor 3 Protein Suppresses the Oncogenic Function of Mutant p53 Proteins
- (2014) Saisai Wei et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Loss of ATF3 promotes Akt activation and prostate cancer development in a Pten knockout mouse model
- (2014) Z Wang et al. ONCOGENE
- The Prolyl Hydroxylase Inhibitor Dimethyloxalylglycine Enhances Dentin Sialophoshoprotein Expression through VEGF-Induced Runx2 Stabilization
- (2014) Saeed Ur Rahman et al. PLoS One
- Induced multipotency in adult keratinocytes through down-regulation ofΔNp63orDGCR8
- (2014) Deepavali Chakravarti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Runx2, a target gene for activating transcription factor-3 in human breast cancer cells
- (2014) M. Gokulnath et al. TUMOR BIOLOGY
- hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: A systematic review
- (2014) Stina Nordh WORLD JOURNAL OF GASTROENTEROLOGY
- miR-203 inhibits tumor cell migration and invasion via caveolin-1 in pancreatic cancer cells
- (2014) LIFENG MIAO et al. Oncology Letters
- Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL
- (2013) A Meijer et al. BRITISH JOURNAL OF CANCER
- The interaction between C35 and ΔNp73 promotes chemo-resistance in ovarian cancer cells
- (2013) T H-Y Leung et al. BRITISH JOURNAL OF CANCER
- Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis
- (2013) W Hanel et al. CELL DEATH AND DIFFERENTIATION
- MicroRNA-34c Inversely Couples the Biological Functions of the Runt-related Transcription Factor RUNX2 and the Tumor Suppressor p53 in Osteosarcoma
- (2013) Margaretha van der Deen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinoma
- (2013) Matthew R. Ramsey et al. JOURNAL OF CLINICAL INVESTIGATION
- p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis
- (2013) Rubeta N. Matin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death
- (2013) Zhiyu Chen et al. Molecular Cancer
- Tumor metastasis: moving new biological insights into the clinic
- (2013) Liling Wan et al. NATURE MEDICINE
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage
- (2013) T Ozaki et al. Cell Death & Disease
- MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes
- (2013) S Nath et al. Oncogenesis
- Recent Advances in Validating MDM2 as a Cancer Target
- (2012) Elizabeth Rayburn et al. Anti-Cancer Agents in Medicinal Chemistry
- Validation of Polo-like kinase 1 as a therapeutic target in pancreatic cancer cells
- (2012) Chao Zhang et al. CANCER BIOLOGY & THERAPY
- miRNA profiling in pancreatic cancer and restoration of chemosensitivity
- (2012) Saurabh Singh et al. CANCER LETTERS
- miR-30 Family Members Negatively Regulate Osteoblast Differentiation
- (2012) Tingting Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Runt-related Transcription Factor 1 (RUNX1) Stimulates Tumor Suppressor p53 Protein in Response to DNA Damage through Complex Formation and Acetylation
- (2012) Dan Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Runx2 Protein Stabilizes Hypoxia-inducible Factor-1α through Competition with von Hippel-Lindau Protein (pVHL) and Stimulates Angiogenesis in Growth Plate Hypertrophic Chondrocytes
- (2012) Sun-Hee Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Plk1 Phosphorylation of Orc2 and Hbo1 Contributes to Gemcitabine Resistance in Pancreatic Cancer
- (2012) B. Song et al. MOLECULAR CANCER THERAPEUTICS
- p53 mutations in cancer
- (2012) Patricia A. J. Muller et al. NATURE CELL BIOLOGY
- Increased Pontin expression is a potential predictor for outcome in sporadic colorectal carcinoma
- (2012) JOHANNES C. LAUSCHER et al. ONCOLOGY REPORTS
- Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients
- (2012) Sang Hyub Lee et al. PATHOLOGY INTERNATIONAL
- A Pin1/Mutant p53 Axis Promotes Aggressiveness in Breast Cancer
- (2011) Javier E. Girardini et al. CANCER CELL
- Prognostic Impact of ΔTAp73 Isoform Levels and Their Target Genes in Colon Cancer Patients
- (2011) Beatriz Soldevilla et al. CLINICAL CANCER RESEARCH
- Pancreatic cancer
- (2011) Audrey Vincent et al. LANCET
- RNA interference against MDM2 suppresses tumor growth and metastasis in pancreatic carcinoma SW1990HM cells
- (2011) Weidong Shi et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2
- (2011) Y. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy
- (2010) Bekim Sadikovic et al. BMC CANCER
- The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS
- (2010) Wu-Gan Zhao et al. CARCINOGENESIS
- MicroRNAs and Cellular Phenotypy
- (2010) Kenneth S. Kosik CELL
- In good times and bad: p73 in cancer
- (2010) Claudia Oswald et al. CELL CYCLE
- Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis
- (2010) Sharanjot Saini et al. CLINICAL CANCER RESEARCH
- miR-301a as an NF-κB activator in pancreatic cancer cells
- (2010) Zhongxin Lu et al. EMBO JOURNAL
- Sp1 binds to the external promoter of the p73 gene and induces the expression of TAp73γ in lung cancer
- (2010) Stella Logotheti et al. FEBS Journal
- Isoform-specific p73 knockout mice reveal a novel role for Np73 in the DNA damage response pathway
- (2010) M. T. Wilhelm et al. GENES & DEVELOPMENT
- RUNX3 Modulates DNA Damage-mediated Phosphorylation of Tumor Suppressor p53 at Ser-15 and Acts as a Co-activator for p53
- (2010) Chizu Yamada et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Runx transcriptional co-activator, CBFβ, is essential for invasion of breast cancer cells
- (2010) Daniel Mendoza-Villanueva et al. Molecular Cancer
- Small RNAs are on the move
- (2010) Daniel H. Chitwood et al. NATURE
- TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs
- (2010) Xiaohua Su et al. NATURE
- Characterization of ΔNp73 expression and regulation in gastric and esophageal tumors
- (2010) A E Vilgelm et al. ONCOGENE
- Elevated Transcript Levels From the MDM2 P1 Promoter and Low p53 Transcript Levels Are Associated With Poor Prognosis in Human Pancreatic Ductal Adenocarcinoma
- (2010) Lukasz Filip Grochola et al. PANCREAS
- The p53 orchestra: Mdm2 and Mdmx set the tone
- (2010) Mark Wade et al. TRENDS IN CELL BIOLOGY
- Perspectives onRUNXgenes: An update
- (2009) M. Michael Cohen Jr. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Genetic Control of Bone Formation
- (2009) Gerard Karsenty et al. Annual Review of Cell and Developmental Biology
- Promyelocytic Leukemia Protein is Required for Gain of Function by Mutant p53
- (2009) S. Haupt et al. CANCER RESEARCH
- Ectopic Runx2 Expression in Mammary Epithelial Cells Disrupts Formation of Normal Acini Structure: Implications for Breast Cancer Progression
- (2009) J. Pratap et al. CANCER RESEARCH
- Genetic alterations and signaling pathways in the evolution of gliomas
- (2009) Hiroko Ohgaki et al. CANCER SCIENCE
- Regulation of bone development and extracellular matrix protein genes by RUNX2
- (2009) Toshihisa Komori CELL AND TISSUE RESEARCH
- Suppression of Androgen-Independent Prostate Cancer Cell Aggressiveness by FTY720: Validating Runx2 as a Potential Antimetastatic Drug Screening Platform
- (2009) C.-W. Chua et al. CLINICAL CANCER RESEARCH
- Runx2 regulates survivin expression in prostate cancer cells
- (2009) Minyoung Lim et al. LABORATORY INVESTIGATION
- A common gain of function of p53 cancer mutants in inducing genetic instability
- (2009) D P Liu et al. ONCOGENE
- Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions
- (2009) J Akech et al. ONCOGENE
- MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
- (2009) Qing Ji et al. PLoS One
- Adenoviral-mediated overexpression of human equilibrative nucleoside transporter 1 (hENT1) enhances gemcitabine response in human pancreatic cancer
- (2008) Sandra Pérez-Torras et al. BIOCHEMICAL PHARMACOLOGY
- Runx2 Transcriptional Activation of Indian Hedgehog and a Downstream Bone Metastatic Pathway in Breast Cancer Cells
- (2008) J. Pratap et al. CANCER RESEARCH
- Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer
- (2008) James J. Farrell et al. GASTROENTEROLOGY
- TAp73 knockout shows genomic instability with infertility and tumor suppressor functions
- (2008) R. Tomasini et al. GENES & DEVELOPMENT
- Expression and Function of Cbfa-1/Runx2 in Thyroid Papillary Carcinoma Cells
- (2008) Toyoshi Endo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway
- (2008) William G. Kaelin et al. MOLECULAR CELL
- Chaperone-dependent stabilization and degradation of p53 mutants
- (2008) P Muller et al. ONCOGENE
- A microRNA signature for a BMP2-induced osteoblast lineage commitment program
- (2008) Z. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started